{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:47:45Z","timestamp":1792651665128,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"am","delay-in-days":380,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.drudis.2019.09.020","type":"journal-article","created":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T11:30:39Z","timestamp":1570102239000},"page":"141-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":139,"title":["Iron oxide nanoparticles for therapeutic applications"],"prefix":"10.1016","volume":"25","author":[{"given":"Edouard","family":"Alphand\u00e9ry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2019.09.020_bib0005","doi-asserted-by":"crossref","first-page":"6620","DOI":"10.1039\/C9NR00531E","article-title":"Unravelling the growth mechanism of the coprecipitation of iron oxide nanoparticles with the aid of synchrotron X-Ray diffraction in solution","volume":"11","author":"Lagrow","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.drudis.2019.09.020_bib0010","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s10973-015-4840-5","article-title":"Thermal decomposition of precursors and iron oxide properties","volume":"123","author":"Dos Santos Monteiro","year":"2016","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.drudis.2019.09.020_bib0015","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3390\/nano8080567","article-title":"Micellar iron oxide nanoparticles coated with anti-tumor glycosides","volume":"8","author":"Groult","year":"2018","journal-title":"Nanomaterials"},{"key":"10.1016\/j.drudis.2019.09.020_bib0020","first-page":"386","article-title":"Synthesis of silica-coated iron oxide nanoparticles: preventing aggregation without using additives or seed pretreatment","volume":"17","author":"Sharafi","year":"2018","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.drudis.2019.09.020_bib0025","doi-asserted-by":"crossref","first-page":"13593","DOI":"10.1021\/jp902953t","article-title":"Facile hydrothermal synthesis of iron oxide nanoparticles with tunable magnetic properties","volume":"113","author":"Ge","year":"2009","journal-title":"J. Phys. Chem. C"},{"key":"10.1016\/j.drudis.2019.09.020_bib0030","doi-asserted-by":"crossref","first-page":"9437487","DOI":"10.1155\/2017\/9437487","article-title":"Superparamagnetic iron oxide (Fe3O4) nanoparticles coated with PEG\/PEI for biomedical applications: a facile and scalable preparation route based on the cathodic electrochemical deposition method","volume":"2017","author":"Karimzadeh","year":"2017","journal-title":"Adv. Phys. Chem."},{"key":"10.1016\/j.drudis.2019.09.020_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics7020046","article-title":"Iron oxide nanoparticles for biomedical applications: a perspective on synthesis, drugs, antimicrobial activity, and toxicity","volume":"7","author":"Arias","year":"2018","journal-title":"Antibiotics"},{"key":"10.1016\/j.drudis.2019.09.020_bib0040","doi-asserted-by":"crossref","first-page":"7840161","DOI":"10.1155\/2016\/7840161","article-title":"Perspective of Fe3O4 nanoparticles role in biomedical applications","volume":"2016","author":"Ghazanfari","year":"2016","journal-title":"Biochem. Res. Int."},{"key":"10.1016\/j.drudis.2019.09.020_bib0045","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1039\/C7CS00657H","article-title":"Construction of iron oxide nanoparticle-based hybrid platforms for tumour imaging and therapy","volume":"47","author":"Hu","year":"2018","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.drudis.2019.09.020_bib0050","doi-asserted-by":"crossref","first-page":"170030","DOI":"10.1002\/adhm.201700306","article-title":"Functionalization, and design of magnetic nanoparticles for theranostic applications","volume":"6","author":"Mosayebi","year":"2017","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.drudis.2019.09.020_bib0055","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/mrm.10406","article-title":"MR molecular imaging of the Her-2\/neu receptor in breast cancer cells using targeted iron oxide nanoparticles","volume":"49","author":"Artemov","year":"2003","journal-title":"Magn. Res. Med."},{"key":"10.1016\/j.drudis.2019.09.020_bib0060","doi-asserted-by":"crossref","first-page":"117","DOI":"10.15171\/bi.2018.14","article-title":"Mucin-1 aptamer-armed superparamagnetic iron oxide nanoparticles for targeted delivery of doxorubicin to breast cancer cells","volume":"8","author":"Aghanejad","year":"2018","journal-title":"BioImpacts"},{"key":"10.1016\/j.drudis.2019.09.020_bib0065","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1158\/0008-5472.CAN-06-1668","article-title":"Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner","volume":"67","author":"Zhang","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.drudis.2019.09.020_bib0070","doi-asserted-by":"crossref","first-page":"6677","DOI":"10.1158\/1078-0432.CCR-06-0946","article-title":"Vascular targeted nanoparticles for imaging and treatment of brain tumors","volume":"12","author":"Reddy","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drudis.2019.09.020_bib0075","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1166\/jbn.2008.007","article-title":"Development of receptor targeted magnetic iron oxide nanoparticles for efficient drug delivery and tumor imaging","volume":"4","author":"Yang","year":"2008","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.drudis.2019.09.020_bib0080","doi-asserted-by":"crossref","first-page":"12692","DOI":"10.1039\/C7DT02139A","article-title":"Folic acid on iron oxide nanoparticles: platform with high potential for simultaneous targeting, MRI detection and hyperthermia treatment of lymph node metastases of prostate cancer","volume":"46","author":"Bonvin","year":"2017","journal-title":"Dalton Trans."},{"key":"10.1016\/j.drudis.2019.09.020_bib0085","doi-asserted-by":"crossref","first-page":"7206","DOI":"10.1021\/ja049195r","article-title":"A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents","volume":"126","author":"Kohler","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.drudis.2019.09.020_bib0090","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10549-006-9199-7","article-title":"LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases","volume":"99","author":"Leuschner","year":"2006","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.drudis.2019.09.020_bib0095","first-page":"1","article-title":"Biodistribution and targeting properties of iron oxide nanoparticles for treatments of cancer and iron anemia disease","volume":"2","author":"Alphand\u00e9ry","year":"2019","journal-title":"Nanotoxicol."},{"key":"10.1016\/j.drudis.2019.09.020_bib0100","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/cbdd.12145","article-title":"Chitosan-coated superparamagnetic iron oxide nanoparticles for doxorubicin delivery: synthesis and anticancer effect against human ovarian cancer cells","volume":"82","author":"Javid","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.drudis.2019.09.020_bib0105","first-page":"90","article-title":"Vinblastine based iron oxide nano drug delivery system","volume":"8","author":"Albermani","year":"2017","journal-title":"J. Glob. Pharma Technol."},{"key":"10.1016\/j.drudis.2019.09.020_bib0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.colsurfb.2016.03.071","article-title":"PSMA targeted docetaxel-loaded superparamagnetic iron oxidenanoparticles for prostate cancer","volume":"144","author":"Nagesh","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.drudis.2019.09.020_bib0115","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12951-015-0083-7","article-title":"Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells","volume":"13","author":"Barar","year":"2015","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.drudis.2019.09.020_bib0120","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ejpb.2016.01.017","article-title":"Pharmaceutical formulation of HSA hybrid coated iron oxide nanoparticles for magnetic drug targeting","volume":"101","author":"Zaloga","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.drudis.2019.09.020_bib0125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.colsurfb.2016.01.054","article-title":"Improving antiproliferative effect of the anticancer drug cytarabine on human promyelocytic leukemia cells by coating on Fe3O4@SiO2 nanoparticles","volume":"141","author":"Shahabadi","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.drudis.2019.09.020_bib0130","first-page":"938","article-title":"Synthesis, characterization and in vitro evaluation of magnetic nanoparticles modified with PCL\u2013PEG\u2013PCL for controlled delivery of 5FU","volume":"46","author":"Asadi","year":"2018","journal-title":"Art. Cell. Nanomed. Biotechnol."},{"key":"10.1016\/j.drudis.2019.09.020_bib0135","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jmmm.2016.01.070","article-title":"Preparation and characterization of polymer nanocomposites coated magnetic nanoparticles for drug delivery applications","volume":"408","author":"Prabha","year":"2016","journal-title":"J. Magn. Magn. Mater."},{"key":"10.1016\/j.drudis.2019.09.020_bib0140","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3390\/molecules23071567","article-title":"Iron oxide nanoparticles in photothermal therapy","volume":"23","author":"Estelrich","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2019.09.020_bib0145","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.colsurfb.2017.01.015","article-title":"Remotely controlled drug release based on iron oxide nanoparticles for specific therapy of cancer","volume":"152","author":"Wu","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.drudis.2019.09.020_bib0150","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/27\/8\/085105","article-title":"Thermosensitive gemcitabine magnetoliposomes for combined hyperthermia and chemotherapy","volume":"27","author":"Ferreira","year":"2016","journal-title":"Nanotechnol"},{"key":"10.1016\/j.drudis.2019.09.020_bib0155","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijpharm.2016.01.043","article-title":"An in vitro evaluation of a carmustine-loaded Nano-co-Plex for potential magnetic-targeted intranasal delivery to the brain","volume":"500","author":"Akilo","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2019.09.020_bib0160","doi-asserted-by":"crossref","first-page":"6117","DOI":"10.1039\/C5TB00664C","article-title":"Design of hybrid nanovehicles for remotely triggered drug release: an overview","volume":"3","author":"Liu","year":"2015","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.drudis.2019.09.020_bib0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158084","article-title":"Magnetic properties of polyvinyl alcohol and doxorubicine loaded iron oxide nanoparticles for anticancer drug delivery applications","volume":"11","author":"Nadeem","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2019.09.020_bib0170","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bioorg.2017.12.033","article-title":"Bovine serum albumin (BSA) coated iron oxide magnetic nanoparticles as biocompatible carriers for curcumin-anticancer drug","volume":"76","author":"Nosrati","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.drudis.2019.09.020_bib0175","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.msec.2015.06.001","article-title":"5-Fluorouracil intercalated iron oxide@layered double hydroxide core-shell nano-composites with isotropic and anisotropic architectures for shape-selective drug delivery applications","volume":"55","author":"Tuncelli","year":"2015","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.drudis.2019.09.020_bib0180","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1080\/03639045.2017.1417422","article-title":"Methotrexate-conjugated l-lysine coated iron oxide magnetic nanoparticles for inhibition of mcf-7 breast cancer cells","volume":"44","author":"Nosrati","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.drudis.2019.09.020_bib0185","doi-asserted-by":"crossref","first-page":"11908","DOI":"10.1021\/acsami.5b01685","article-title":"Drug\/dye-loaded, multifunctional PEG\u2212chitosan\u2212iron oxide nanocomposites for methotraxate synergistically self-targeted cancer therapy and dual model imaging","volume":"7","author":"Lin","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.drudis.2019.09.020_bib0190","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.1021\/acs.iecr.7b00990","article-title":"Protease-sensitive nanomaterials for cancer therapeutics and imaging","volume":"56","author":"Anderson","year":"2017","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.drudis.2019.09.020_bib0195","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/smll.201301456","article-title":"Development of novel tumour-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy","volume":"10","author":"Ansari","year":"2014","journal-title":"Small"},{"key":"10.1016\/j.drudis.2019.09.020_bib0200","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.biomaterials.2015.09.030","article-title":"In vivo dual-targeted chemotherapy of drug resistant cancer by rationally designed nanocarrier","volume":"75","author":"Wang","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.drudis.2019.09.020_bib0205","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.ijbiomac.2016.09.043","article-title":"Effect of crosslinker on drug delivery properties of curcumin loaded starch coated iron oxide nanoparticles","volume":"93","author":"Saikia","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.drudis.2019.09.020_bib0210","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1021\/acs.nanolett.6b04269","article-title":"Enhanced cisplatin chemotherapy by iron oxide nanocarrier-mediated generation of highly toxic reactive oxygen species","volume":"17","author":"Ma","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.drudis.2019.09.020_bib0215","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.drudis.2017.04.008","article-title":"Next generation superparamagnetic iron oxide nanoparticles for cancer theranostics","volume":"22","author":"Li","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2019.09.020_bib0220","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.biomaterials.2017.06.026","article-title":"Development of non-pyrogenic magnetosome minerals coated with poly-l-lysine leading to full disappearance of intracranial U87-Luc glioblastoma in 100% of treated mice using magnetic hyperthermia","volume":"141","author":"Alphand\u00e9ry","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.drudis.2019.09.020_bib0225","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jconrel.2017.07.020","article-title":"Chains of magnetosomes with controlled endotoxin release and partial tumour occupation induce full destruction of intracranial U87-Luc glioma in mice under the application of an alternating magnetic field","volume":"261","author":"Alphand\u00e9ry","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2019.09.020_bib0230","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.7150\/thno.18927","article-title":"Enhanced antitumour efficacy of biocompatible magnetosomes for the magnetic hyperthermia treatment of glioblastoma","volume":"7","author":"Le F\u00e8vre","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.drudis.2019.09.020_bib0235","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12951-017-0293-2","article-title":"Biocompatible coated magnetosome minerals with various organization and cellular interaction properties induce cytotoxicity towards RG\u20112 and GL\u2011261 glioma cells in the presence of an alternating magnetic field","volume":"15","author":"Hamdous","year":"2017","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.drudis.2019.09.020_bib0240","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.1039\/C6TB03248F","article-title":"Biocompatible and stable magnetosome minerals coated with poly-l-lysine, citric acid, oleic acid, and carboxy-methyl-dextran for application in the magnetic hyperthermia treatment of tumours","volume":"5","author":"Mandawala","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.drudis.2019.09.020_bib0245","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3109\/02656736.2013.832815","article-title":"In vivo applications of magnetic nanoparticle hyperthermia","volume":"29","author":"Hilger","year":"2013","journal-title":"Int. J. Hyperthermia"},{"key":"10.1016\/j.drudis.2019.09.020_bib0250","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3390\/nano8070468","article-title":"Combined treatments of magnetic intra-lysosomal hyperthermia with doxorubicin promotes synergistic anti-tumoral activity","volume":"8","author":"Hajj","year":"2018","journal-title":"Nanomaterials"},{"key":"10.1016\/j.drudis.2019.09.020_bib0255","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11060-010-0389-0","article-title":"Efficacy and safety of intratumoural thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme","volume":"103","author":"Maier-Hauff","year":"2011","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.drudis.2019.09.020_bib0260","doi-asserted-by":"crossref","DOI":"10.5772\/58841","article-title":"Engineering iron oxide nanoparticles for clinical settings","author":"Cortajarena","year":"2014","journal-title":"Nanobiomedicine"},{"key":"10.1016\/j.drudis.2019.09.020_bib0265","doi-asserted-by":"crossref","first-page":"33560","DOI":"10.1038\/srep33560","article-title":"Remote actuation of magnetic nanoparticles for cancer cell selective treatment through cytoskeletal disruption","volume":"6","author":"Master","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drudis.2019.09.020_bib0270","first-page":"17","article-title":"Magnetic nanoparticle hyperthermia in cancer treatment","volume":"1","author":"Giustini","year":"2011","journal-title":"Nanolife"},{"key":"10.1016\/j.drudis.2019.09.020_bib0275","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/biot.201100045","article-title":"Cancer hyperthermia using magnetic nanoparticles","volume":"6","author":"Kobayashi","year":"2011","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.drudis.2019.09.020_bib0280","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.tibs.2016.01.003","article-title":"Heat shock proteins promote cancer: it\u2019s a protection racket","volume":"41","author":"Calderwood","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.drudis.2019.09.020_bib0285","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.biotechadv.2016.04.005","article-title":"Hypoxic tumour microenvironment: opportunities to develop targeted therapies","volume":"34","author":"Patel","year":"2016","journal-title":"Biotechnol. Adv"},{"key":"10.1016\/j.drudis.2019.09.020_bib0290","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1021\/ar2000277","article-title":"Surface engineering of iron oxide nanoparticles for targeted cancer therapy","volume":"44","author":"Kievit","year":"2011","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.drudis.2019.09.020_bib0295","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1136\/gutjnl-2016-311393","article-title":"Tumour-specific delivery of siRNA-coupled superparamagnetic iron oxide nanoparticles, targeted against PLK1, stops progression of pancreatic cancer","volume":"65","author":"Mahajan","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.drudis.2019.09.020_bib0300","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11771-012-1009-2","article-title":"Magnetic iron oxide nanoparticles carrying PTEN gene to reverse cisplatin-resistance of A549\/CDDP cell lines","volume":"19","author":"Min","year":"2012","journal-title":"J. Cent. S. Univ."},{"key":"10.1016\/j.drudis.2019.09.020_bib0305","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1021\/bc5005203","article-title":"Magnetofection mediated transient NANOG overexpression enhances proliferation and myogenic differentiation of human hair follicle derived mesenchymal stem cells","volume":"26","author":"Son","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.drudis.2019.09.020_bib0310","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/2052-8426-2-27","article-title":"Gene therapy for cancer: present status and future perspective","volume":"2","author":"Amer","year":"2014","journal-title":"Mol. Cell Ther."},{"key":"10.1016\/j.drudis.2019.09.020_bib0315","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.2147\/IJN.S168268","article-title":"A GPC3-specific aptamer-mediated magnetic resonance probe for hepatocellular carcinoma","volume":"13","author":"Zhao","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.drudis.2019.09.020_bib0320","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2217\/rme.15.36","article-title":"Advanced cell therapies: targeting, tracking and actuation of cells with magnetic particles","volume":"10","author":"Connell","year":"2015","journal-title":"Regen. Med."},{"key":"10.1016\/j.drudis.2019.09.020_bib0325","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bbrc.2013.10.115","article-title":"SPION primes THP1 derived M2 macrophages towards M1-like macrophages","volume":"441","author":"Laskar","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drudis.2019.09.020_bib0330","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/nnano.2016.168","article-title":"Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues","volume":"11","author":"Zanganeh","year":"2016","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.drudis.2019.09.020_bib0335","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.7150\/thno.19738","article-title":"Iron oxide nanozyme: a multifunctional enzyme mimetic for biomedical applications","volume":"7","author":"Gao","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.drudis.2019.09.020_bib0340","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.drudis.2017.04.018","article-title":"Magnetic nanoformulations for prostate cancer","volume":"22","author":"Chowdhury","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2019.09.020_bib0345","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jconrel.2018.11.013","article-title":"Reviewing two decades of nanomedicine implementations in targeted treatment and diagnosis of pancreatic cancer: an emphasis on state of art","volume":"293","author":"El-Zahabya","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2019.09.020_bib0350","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s13205-018-1286-z","article-title":"Recent advances and future prospects of iron oxide nanoparticles in biomedicine and diagnostics","volume":"8","author":"Srikanth Vallabani","year":"2018","journal-title":"3 Biotech."},{"key":"10.1016\/j.drudis.2019.09.020_bib0355","doi-asserted-by":"crossref","first-page":"1701156","DOI":"10.1002\/adhm.201701156","article-title":"Tumour microenvironment-enabled nanotherapy","volume":"7","author":"Wang","year":"2018","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.drudis.2019.09.020_bib0360","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.nano.2011.03.008","article-title":"Nanotechnologies for Alzheimer\u2019s disease: diagnosis, therapy, and safety issues","volume":"7","author":"Brambilla","year":"2011","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.drudis.2019.09.020_bib0365","doi-asserted-by":"crossref","first-page":"344","DOI":"10.7150\/thno.16562","article-title":"Inhibition by multifunctional magnetic nanoparticles loaded with alpha-synuclein RNAi plasmid in a Parkinson\u2019s disease model","volume":"7","author":"Niu","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.drudis.2019.09.020_bib0370","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1166\/jnn.2016.11103","article-title":"Neuroprotective potential of superparamagnetic iron oxide nanoparticles along with exposure to electromagnetic field in 6-OHDA rat model of Parkinson\u2019s disease","volume":"16","author":"Umarao","year":"2016","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.drudis.2019.09.020_bib0375","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13041-016-0236-0","article-title":"Magnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuse","volume":"9","author":"Sagar","year":"2016","journal-title":"Mol. Brain"},{"key":"10.1016\/j.drudis.2019.09.020_bib0380","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.micpath.2017.12.068","article-title":"Preparation, characterization and antifungal activity of iron oxide nanoparticles","volume":"115","author":"Parveen","year":"2018","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.drudis.2019.09.020_bib0385","doi-asserted-by":"crossref","first-page":"14813","DOI":"10.1038\/srep14813","article-title":"Antimicrobial activity of iron oxide nanoparticle upon modulation of nanoparticle-bacteria interface","volume":"5","author":"Arakha","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drudis.2019.09.020_bib0390","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2147\/IJN.S121956","article-title":"The antimicrobial activity of nanoparticles: present situation and prospects for the future","volume":"12","author":"Wang","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.drudis.2019.09.020_bib0395","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1002\/smll.201501820","article-title":"Optimization of pathogen capture in flowing fluids with magnetic nanoparticles","volume":"11","author":"Kang","year":"2015","journal-title":"Small"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644619303800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644619303800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:45:33Z","timestamp":1761223533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644619303800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1359644619303800"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2019.09.020","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iron oxide nanoparticles for therapeutic applications","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2019.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}